Evidence map›Paper›PMID 42555572›Full record

ArticlePloS one2026

Integrating disease mapping and flexible scan statistics to identify and visualize spatial clusters.

Lina Wang, Haoqi Hu, Yaru Li, Danfei Zhang, Xiang Li, Zhengbin Zhang

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lina WangSchool of Computer Science and Artificial Intelligence, Zhengzhou University of Light Industry, Zhengzhou, Henan, China.ORCID https://orcid.org/0009-0006-3187-9857
Haoqi HuSchool of Computer Science and Artificial Intelligence, Zhengzhou University of Light Industry, Zhengzhou, Henan, China.
Yaru LiSchool of Computer Science and Artificial Intelligence, Zhengzhou University of Light Industry, Zhengzhou, Henan, China.
Danfei ZhangInstitute of Surveying and Mapping, Information Engineering University, Zhengzhou, Henan, China.
Xiang LiInstitute of Surveying and Mapping, Information Engineering University, Zhengzhou, Henan, China.
Zhengbin ZhangTuberculosis Prevention and Control Office, Wuhan Pulmonary Hospital (Wuhan Institute for Tuberculosis Control), Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurately characterizing the spatial distribution of diseases is essential for understanding etiology and guiding targeted public health interventions. This study develops an analytical framework integrating disease mapping and spatial scan statistics to identify and validate the spatial clustering patterns of diseases. The framework follows an "exploration-validation-refinement" workflow, combining qualitative visualization with quantitative spatial analysis. Choropleth maps intuitively depict the overall distribution of diseases, providing a basis for identifying potential high-risk areas; the flexible scan statistics (FleXScan) method detects statistically significant clusters; and dot cartograms further reveal internal heterogeneity within the most likely clusters by controlling for population density. This study validated the framework using both synthetic data and real measles case data. The results indicate that the framework substantially improves the accuracy and reliability of cluster detection, facilitates the localization of local high-risk cores, and provides actionable insights for precision disease control.

Indexed as

MeaslesCluster AnalysisClustering AlgorithmsHumansSpatial Analysis

Identifiers

PMID42555572
PMCPMC13440791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.